[{"address1": "2656 State Street", "city": "Carlsbad", "state": "CA", "zip": "92008", "country": "United States", "phone": "619-728-4760", "website": "https://tyra.bio", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SN\u00c5P, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.", "fullTimeEmployees": 60, "companyOfficers": [{"maxAge": 1, "name": "Dr. Todd  Harris Ph.D.", "age": 45, "title": "Co-Founder, President, CEO, Secretary, Treasurer & Director", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 1067050, "exercisedValue": 0, "unexercisedValue": 7050750}, {"maxAge": 1, "name": "Mr. Erik  Goluboff", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ralph William Charlton III, M.D.", "age": 54, "title": "Senior Vice President of Clinical Development", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sinette  Heys", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Amy  Conrad", "title": "Investor Contact", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 9, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.09, "open": 9.99, "dayLow": 9.735, "dayHigh": 10.09, "regularMarketPreviousClose": 10.09, "regularMarketOpen": 9.99, "regularMarketDayLow": 9.735, "regularMarketDayHigh": 10.09, "payoutRatio": 0.0, "beta": 1.187, "forwardPE": -4.970297, "volume": 96250, "regularMarketVolume": 96250, "averageVolume": 313204, "averageVolume10days": 238150, "averageDailyVolume10Day": 238150, "bid": 9.99, "ask": 10.13, "bidSize": 1, "askSize": 1, "marketCap": 535677184, "fiftyTwoWeekLow": 6.42, "fiftyTwoWeekHigh": 29.6, "fiftyDayAverage": 10.3106, "twoHundredDayAverage": 16.6597, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 197804176, "profitMargins": 0.0, "floatShares": 21075120, "sharesOutstanding": 53090000, "sharesShort": 3935750, "sharesShortPriorMonth": 3915958, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.074099995, "heldPercentInsiders": 0.041739997, "heldPercentInstitutions": 0.95816004, "shortRatio": 11.55, "shortPercentOfFloat": 0.1088, "impliedSharesOutstanding": 53354300, "bookValue": 6.762, "priceToBook": 1.4847678, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -86481000, "trailingEps": -1.51, "forwardEps": -2.02, "enterpriseToEbitda": -1.908, "52WeekChange": -0.38966566, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 10.04, "targetHighPrice": 33.0, "targetLowPrice": 28.0, "targetMeanPrice": 30.0, "targetMedianPrice": 30.0, "recommendationKey": "none", "numberOfAnalystOpinions": 6, "totalCash": 341440992, "totalCashPerShare": 6.431, "ebitda": -103658000, "totalDebt": 6222000, "quickRatio": 23.533, "currentRatio": 23.809, "debtToEquity": 1.813, "returnOnAssets": -0.22093001, "returnOnEquity": -0.31596002, "freeCashflow": -41145624, "operatingCashflow": -69774000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TYRA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "firstTradeDateMilliseconds": 1631712600000, "postMarketChangePercent": 0.0, "postMarketPrice": 10.04, "postMarketChange": 0.0, "regularMarketChange": -0.05000019, "regularMarketDayRange": "9.735 - 10.09", "shortName": "Tyra Biosciences, Inc.", "hasPrePostMarketData": true, "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 313204, "fiftyTwoWeekLowChange": 3.62, "fiftyTwoWeekLowChangePercent": 0.5638629, "fiftyTwoWeekRange": "6.42 - 29.6", "fiftyTwoWeekHighChange": -19.560001, "fiftyTwoWeekHighChangePercent": -0.6608108, "fiftyTwoWeekChangePercent": -38.966568, "earningsTimestamp": 1743105904, "earningsTimestampStart": 1746648000, "earningsTimestampEnd": 1747080000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.51, "epsForward": -2.02, "epsCurrentYear": -2.10883, "priceEpsCurrentYear": -4.760934, "fiftyDayAverageChange": -0.27060032, "fiftyDayAverageChangePercent": -0.026244866, "twoHundredDayAverageChange": -6.6197004, "twoHundredDayAverageChangePercent": -0.3973481, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-09-15", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1745611315, "regularMarketTime": 1745611201, "exchange": "NMS", "messageBoardId": "finmb_650787124", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.49554202, "regularMarketPrice": 10.04, "longName": "Tyra Biosciences, Inc.", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]